Andrew Hammond, co-founder of Biocentis with a molecular biology background, and Mairi Gibbs, CEO of Oxford University Innovation, delve into the complexities of commercializing academic research. They discuss the critical stages for transforming ideas into viable businesses, the importance of intellectual property, and investor insights. Topics include the societal impact of spin-outs, gender imbalances in funding, and the role of innovations like gene drive technology in addressing global challenges. Their conversations highlight the collaboration needed to navigate this intricate landscape.
